Sacchettini James C, Rubin Eric J, Freundlich Joel S
Department of Biochemistry and Biophysics, Texas A&M University, College Station, Texas 77843, USA.
Nat Rev Microbiol. 2008 Jan;6(1):41-52. doi: 10.1038/nrmicro1816.
Tuberculosis (TB) claims a life every 10 seconds and global mortality rates are increasing despite the use of chemotherapy. But why have we not progressed towards the eradication of the disease? There is no simple answer, although apathy, politics, poverty and our inability to fight the chronic infection have all contributed. Drug resistance and HIV-1 are also greatly influencing the current TB battle plans, as our understanding of their complicity grows. In this Review, recent efforts to fight TB will be described, specifically focusing on how drug discovery could combat the resistance and persistence that make TB worthy of the moniker 'The Great White Plague'.
结核病每10秒钟就会夺走一条生命,尽管使用了化疗,但全球死亡率仍在上升。但为什么我们在根除这种疾病方面没有取得进展呢?虽然冷漠、政治、贫困以及我们对抗这种慢性感染的无能都起到了一定作用,但并没有简单的答案。随着我们对耐药性和HIV-1之间关联的认识不断加深,它们也对当前的结核病防治计划产生了巨大影响。在这篇综述中,将描述近期抗击结核病的努力,特别关注药物研发如何对抗耐药性和持续性,正是这些因素使得结核病无愧于“白色瘟疫”这一称谓。